Meeting abstract
A view to the RA treatment safety profile - what will the data on long-term biologics application bring
Jadranka Morović-Vergles
; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital “Dubrava”, Zagreb, Croatia
Full text: croatian pdf 411 Kb
page 175-175
downloads: 207
cite
APA 6th Edition
Morović-Vergles, J. (2013). A view to the RA treatment safety profile - what will the data on long-term biologics application bring. Reumatizam, 60 (2), 175-175. Retrieved from https://hrcak.srce.hr/index.php/123453
MLA 8th Edition
Morović-Vergles, Jadranka. "A view to the RA treatment safety profile - what will the data on long-term biologics application bring." Reumatizam, vol. 60, no. 2, 2013, pp. 175-175. https://hrcak.srce.hr/index.php/123453. Accessed 20 May 2024.
Chicago 17th Edition
Morović-Vergles, Jadranka. "A view to the RA treatment safety profile - what will the data on long-term biologics application bring." Reumatizam 60, no. 2 (2013): 175-175. https://hrcak.srce.hr/index.php/123453
Harvard
Morović-Vergles, J. (2013). 'A view to the RA treatment safety profile - what will the data on long-term biologics application bring', Reumatizam, 60(2), pp. 175-175. Available at: https://hrcak.srce.hr/index.php/123453 (Accessed 20 May 2024)
Vancouver
Morović-Vergles J. A view to the RA treatment safety profile - what will the data on long-term biologics application bring. Reumatizam [Internet]. 2013 [cited 2024 May 20];60(2):175-175. Available from: https://hrcak.srce.hr/index.php/123453
IEEE
J. Morović-Vergles, "A view to the RA treatment safety profile - what will the data on long-term biologics application bring", Reumatizam, vol.60, no. 2, pp. 175-175, 2013. [Online]. Available: https://hrcak.srce.hr/index.php/123453. [Accessed: 20 May 2024]
Abstract
Keywords
Hrčak ID:
123453
URI
https://hrcak.srce.hr/123453
Publication date:
17.10.2013.
Article data in other languages:
croatian
Visits: 682
*
